However, genetic screening for pancreatitis-causing genes in ALL patients is not currently standard practice, which limits our understanding of the impact of specific genetic variants on the development of AAP in pediatric ALL receiving asparaginase therapy. The gene discussed is ASPG; the disease is pancreatitis.